Protein detection and quantification are daily occurrences both in research and diagnostic laboratories. Also, follow-ups of therapeutic treatments and prognoses have grown to rely more and more on ...

Since Henry Bence Jones first discovered a urine protein marker for multiple myeloma in 1846, the field of cancer biomarkers has grown exponentially. Over the past two centuries, scientists have ...

The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and chemotherapy resistance in ovarian cancer cells, findings that may inform new ...

Immune system cells called macrophages play an unexpected role in the complicated connection between obesity and cancer, a Vanderbilt University Medical Center-led research team has discovered. While ...

Wildlife biologist Marissa Irwin had no idea that cells in her body had gone haywire. In response to scrambled protein signaling pathways, certain cells turned cancerous and grew into tumors that took ...

As illustrated by Dr. Carl Borrebaeck, [4] of Lund University, Sweden, bioarrays may be based on proteins or on affinity reagents. Defined sets of proteins, such as autoantigens, are spotted on ...